Ricerca avanzata

Wael Sawan is currently the Chief Executive Officer at Shell U.K.
Ltd., Shell Plc, and Shell Integrated Gas Oman BV.
He is also the Executive Vice President at Shell Offshore, Inc. Previously, he served as the Chairman & Executive Vice President at Qatar Shell Service Co. WLL from 2012 to 2015.
Mr. Sawan holds a graduate degree from McGill University and an MBA from Harvard Business School.

Wael Yared è Chief Technology Officer, Executive VP, Head-R&D presso Tecan Group AG. Nella sua carriera passata il Dr. Yared è stato direttore generale presso la Arthur D. Little, Inc., CTO e VP-Sviluppo aziendale presso BioAnalytix, Inc., vicepresidente della ricerca e sviluppo presso VisEn Medical, Inc., direttore del Cambridge Strategic Management Group, Inc. e direttore della Polaroid Corp. Ha ricevuto un dottorato dal Massachusetts Institute of Technology.

Il signor Wael Emad Al-Turk è un direttore finanziario alla Jabal Omar Development Co.

Wael Mohamed è nel consiglio di amministrazione di Trend Micro, Inc.

Sawan Tanna currently works as a Treasurer at Gold Corp.
Currently, he holds the position of Treasurer at Gold Corp.

Sawan Pipoosananont is currently the Director-Corporate Marketing Division at SE-Education Public Co. Ltd.
Previously, from 2001 to 2015, she worked as the Executive Editor at Post International Media Co. Ltd.
She has an undergraduate degree from the University of Chulalongkorn and a graduate degree from the National Institute of Dramatic Art.

Sam Sawan is the founder of Neosil, Inc. (founded in 2004) and OsteoGenix, Inc. (founded in 2005).
He is currently a Director at Theracaine LLC, a Legal Counsel at Open Text Corp.
(since 2022), a Faculty Member at the University of Massachusetts, and a Principal at Shalon Ventures, Inc. (since 2000).
He was previously a Director & Corporate Counsel at Spartan Race, Inc. (2019-2022).
Dr. Sawan holds a doctorate from the University of Massachusetts and an undergraduate degree from Williams College (conferred in 2006).

Sawan Kuman Okrawan is currently the Chief Executive Officer & Director at Abatek (Asia) Public Co., Ltd.
since 2018.
He is also the Chairman & Chief Executive Officer at Abatek Malaysia Industries since 2014, Chairman & Chief Executive Officer at Dongguan Abatek Electronics co., ltd.
since 2013, Chairman & Chief Executive Officer at Abatek Kunshan Electronics Trading Co., Ltd.
since 2012, Chairman at Abatek (Americas), Inc. since 2006, and Director & Deputy Managing Director at Abatek International AG since 2006.
He completed his undergraduate degree at the University of Calcutta and holds an MBA from Ramkhamhaeng University.

Wael Nabulsi, who previously worked at Abu Dhabi National Energy Co. PJSC as Head-Internal Audit, Ernst & Young LLP (Missouri) as Manager, and Dolphin Energy Ltd.
as Manager-Internal Audit.

Wael Mohammed Musa Barakat served as an Independent Non-Executive Director at The Islamic Insurance Co. and as an Assistant General Manager at Jordan Islamic Bank.
He obtained his undergraduate degree from Beirut Arab University in 1972.

Wael Fakhry worked as the Chief Financial Officer & Vice President at Beth Israel Medical Center and as a Principal at Lutheran Health Systems and NYU Langone Health.
He also served as the Senior Vice President-Financial Operations at City of Hope National Cancer Institute from 2012 to 2015 and as the Chief Financial Officer & Senior Vice President at Indian River Medical Center Foundation.
Fakhry received his undergraduate degree from Ain Shams University.

Mr. Wael Kanaan is a Manager-Business Development & Pharma at Medical Supplies & Services Co. (Palestine).
Mr. Kanaan was previously employed as a Principal by Eli Lilly & Co. He received his undergraduate degree from Adamson University and a graduate degree from the University of Santo Tomas.

Mr. Fayad is a Managing Director at Hildred Capital Management, where he currently serves on the Board of Directors of three Hildred portfolio companies: Project Natural, Carlin Consumer Health, and Crown Laboratories.
Mr. Fayad previously served in an operating role at Hildred Capital Partners, closely involved with certain Hildred portfolio companies, leveraging his depth of experience to enhance strategic positioning, operational efficiency and overall growth trajectory, most notably as Chief Business Officer of Crown Laboratories.
Prior to Hildred, Mr. Fayad spent more than 25 years in pharma and biotech where he started his career in sales, marketing, and new products at Novartis and then Schering-Plough.
He worked at Forest Laboratories Inc. for 14 years and served as Corporate Vice President of Business Development.
After leaving Forest, he advised and worked with biotech and start-up life sciences companies including co-founding Accoy Pharmaceuticals and serving as Chairman and CEO of Enumeral Biomedical.
Through his personal and professional experience, Mr. Fayad developed a deep appreciation for authenticity to build long term value.
Outside of work, he enjoys the outdoors, reading, and spending time with friends and family.
He holds a Bachelor of Science in Biology from the American University of Beirut and an MBA from Concordia University.

Mr. Wael Yacoub Al-Qatami is Chief Executive Officer at Al-Mulla International Financing & Investment Co. KSCC.
He is on the Board of Directors at Warba Bank KSC.
Mr. Al-Qatami was previously employed as Chief Executive Officer by Osoul Investment Co. KSCC.
He received his undergraduate degree from The University of Tampa, Inc.

Wael Abdel Qader Abdullah Al-Qadi is currently a Director at Arab Jordan Investment Bank and a Non-Executive Director at Mediterranean Tourism Investment Co. He was previously a Director at Palestine Investment Bank.
He received his undergraduate degree from Boston University in 1990.

Wael Nabil Abdou Elkhouly is currently working as an Asset Management Managing Director at Infracapital Partners, and as a Director at both Deltic Top Invest Ltd.
and Deltic Top Holding Ltd.
He previously worked as a Principal at Citigroup Asset Management and as the Head of Asset Management at Eiser Infrastructure Partners LLP.

Mr. Wael Ibrahem Al-Yahya is a Manager-Human Resources at Osoul Investment Co. KSCC.

Mr. Wael Ghonim is Co-Founder at Parlio, Inc. Mr. Ghonim was previously employed as a Manager-Marketing & Sales by Gawab.com.
He received his undergraduate degree from the University of Cairo and an MBA from The American University in Cairo.

Mr. Wael Adel Mostafa El-Menoufy is a Chief Commercial Technical Officer at Emaar Misr for Development SAE and a Chief Technical Commercial Officer at Emaar Properties PJSC.
He received his undergraduate degree from the University of Cairo.

Wael Al-Sharif served as the Chief Executive Officer at Takaful Emarat PSC from 2013 to 2018 and again from 2019 to 2023.

Wael Mohamed Salama Ali Mohammed currently works as a Non-Executive Director at MISR Intercontinental for Granite & Marble.

Wael Abdelhamid Al-Ganainy is currently the Chief Medical Officer at Saudi German Hospitals Group in Saudi Arabia since 2007.
Prior to this, he worked as the Chief Medical Officer at Middle East Healthcare Co. He completed his graduate degree from George Washington University in 2003, his graduate degree from Ain Shams University in 2000, and his undergraduate degree from Mansoura University in 1992.

Mr. Wael Saleh Mahmoud Shakirat was previously employed as a Chairman by Al-Qaria Food & Vegetable Oil Industries Co. Plc.
He received his undergraduate degree from The University of Jordan.

Mr. Wael Ezzeldeen Mohamed Arafa is on the Board of Directors at Bahrain Car Park Co. BSC.
He received his undergraduate degree from Helwan University and a graduate degree from George Washington University.

Wael Zeyadah has a current job as a Non-Executive Director at Banque du Caire SAE.

Khoury Wael currently works as a Director at Interaudi Bank.

Waël Rizk is currently a Director at STOA SA in Paris.
Previously, he held Director positions at Icade SA and Transdev Group SA.